APO Research

APO RESEARCH · REPORT

Non-ionic Iodine Contrast Media

Selected research

Market Outlook & Growth Opportunities

Global Non-ionic Iodine Contrast Media Market Outlook and Growth Opportunities 2026

Market perspective

The global Non-ionic Iodine Contrast Media market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-ionic Iodine Contrast Media market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-ionic Iodine Contrast Media market include YRPG, Hengrui Medicine, BeiLu Pharma, Bayer, Sanochemia, Imax, Guerbet Group, GE Healthcare and Bracco Imaging, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-ionic Iodine Contrast Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-ionic Iodine Contrast Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-ionic Iodine Contrast Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-ionic Iodine Contrast Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-ionic Iodine Contrast Media Segment by Company

YRPG

Hengrui Medicine

BeiLu Pharma

Bayer

Sanochemia

Imax

Guerbet Group

GE Healthcare

Bracco Imaging

Non-ionic Iodine Contrast Media Segment by Type

Iopamidol

Iodixanol

Iohexol

Ioversol

Others

Non-ionic Iodine Contrast Media Segment by Application

Hospitals

Clinics

Non-ionic Iodine Contrast Media Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Non-ionic Iodine Contrast Media status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-ionic Iodine Contrast Media market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-ionic Iodine Contrast Media significant trends, drivers, influence factors in global and regions.

6. To analyze Non-ionic Iodine Contrast Media competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-ionic Iodine Contrast Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-ionic Iodine Contrast Media and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-ionic Iodine Contrast Media.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-ionic Iodine Contrast Media market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-ionic Iodine Contrast Media industry.

Chapter 3: Detailed analysis of Non-ionic Iodine Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-ionic Iodine Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-ionic Iodine Contrast Media in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-ionic Iodine Contrast Media Industry Trends Table 2. Non-ionic Iodine Contrast Media Industry Drivers Table 3. Non-ionic Iodine Contrast Media Industry Opportunities and Challenges Table 4. Non-ionic Iodine Contrast Media Industry Restraints Table 5. Global Non-ionic Iodine Contrast Media Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-ionic Iodine Contrast Media Revenue Share by Company (2021-2026) Table 7. Global Non-ionic Iodine Contrast Media Sales Volume by Company (K L) & (2021-2026) Table 8. Global Non-ionic Iodine Contrast Media Sales Volume Share by Company (2021-2026) Table 9. Global Non-ionic Iodine Contrast Media Average Price (US$/L) of Company (2021-2026) Table 10. Global Non-ionic Iodine Contrast Media Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-ionic Iodine Contrast Media Key Company Manufacturing Base & Headquarters Table 12. Global Non-ionic Iodine Contrast Media Company, Product Type & Application Table 13. Global Non-ionic Iodine Contrast Media Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-ionic Iodine Contrast Media by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Iopamidol Table 18. Significant Companies of Iodixanol Table 19. Significant Companies of Iohexol Table 20. Significant Companies of Ioversol Table 21. Significant Companies of Others Table 22. Global Non-ionic Iodine Contrast Media Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 23. Global Non-ionic Iodine Contrast Media Sales Volume by Type (2021-2026) & (K L) Table 24. Global Non-ionic Iodine Contrast Media Sales Volume by Type (2027-2032) & (K L) Table 25. Global Non-ionic Iodine Contrast Media Sales Volume Share by Type (2021-2026) Table 26. Global Non-ionic Iodine Contrast Media Sales Volume Share by Type (2027-2032) Table 27. Global Non-ionic Iodine Contrast Media Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Non-ionic Iodine Contrast Media Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Non-ionic Iodine Contrast Media Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Non-ionic Iodine Contrast Media Sales Value Share by Type (2021-2026) Table 31. Global Non-ionic Iodine Contrast Media Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Clinics Table 34. Global Non-ionic Iodine Contrast Media Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 35. Global Non-ionic Iodine Contrast Media Sales Volume by Application (2021-2026) & (K L) Table 36. Global Non-ionic Iodine Contrast Media Sales Volume by Application (2027-2032) & (K L) Table 37. Global Non-ionic Iodine Contrast Media Sales Volume Share by Application (2021-2026) Table 38. Global Non-ionic Iodine Contrast Media Sales Volume Share by Application (2027-2032) Table 39. Global Non-ionic Iodine Contrast Media Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Non-ionic Iodine Contrast Media Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Non-ionic Iodine Contrast Media Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Non-ionic Iodine Contrast Media Sales Value Share by Application (2021-2026) Table 43. Global Non-ionic Iodine Contrast Media Sales Value Share by Application (2027-2032) Table 44. Global Non-ionic Iodine Contrast Media Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 45. Global Non-ionic Iodine Contrast Media Sales by Region (2021-2026) & (K L) Table 46. Global Non-ionic Iodine Contrast Media Sales Market Share by Region (2021-2026) Table 47. Global Non-ionic Iodine Contrast Media Sales by Region (2027-2032) & (K L) Table 48. Global Non-ionic Iodine Contrast Media Sales Market Share by Region (2027-2032) Table 49. Global Non-ionic Iodine Contrast Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Non-ionic Iodine Contrast Media Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Non-ionic Iodine Contrast Media Sales Value Share by Region (2021-2026) Table 52. Global Non-ionic Iodine Contrast Media Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Non-ionic Iodine Contrast Media Sales Value Share by Region (2027-2032) Table 54. Global Non-ionic Iodine Contrast Media Market Average Price (US$/L) by Region (2021-2026) Table 55. Global Non-ionic Iodine Contrast Media Market Average Price (US$/L) by Region (2027-2032) Table 56. Global Non-ionic Iodine Contrast Media Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 57. Global Non-ionic Iodine Contrast Media Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Non-ionic Iodine Contrast Media Sales by Country (2021-2026) & (K L) Table 59. Global Non-ionic Iodine Contrast Media Sales Market Share by Country (2021-2026) Table 60. Global Non-ionic Iodine Contrast Media Sales by Country (2027-2032) & (K L) Table 61. Global Non-ionic Iodine Contrast Media Sales Market Share by Country (2027-2032) Table 62. Global Non-ionic Iodine Contrast Media Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Non-ionic Iodine Contrast Media Sales Value Market Share by Country (2021-2026) Table 64. Global Non-ionic Iodine Contrast Media Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Non-ionic Iodine Contrast Media Sales Value Market Share by Country (2027-2032) Table 66. YRPG Company Information Table 67. YRPG Business Overview Table 68. YRPG Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 69. YRPG Non-ionic Iodine Contrast Media Product Portfolio Table 70. YRPG Recent Development Table 71. Hengrui Medicine Company Information Table 72. Hengrui Medicine Business Overview Table 73. Hengrui Medicine Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 74. Hengrui Medicine Non-ionic Iodine Contrast Media Product Portfolio Table 75. Hengrui Medicine Recent Development Table 76. BeiLu Pharma Company Information Table 77. BeiLu Pharma Business Overview Table 78. BeiLu Pharma Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 79. BeiLu Pharma Non-ionic Iodine Contrast Media Product Portfolio Table 80. BeiLu Pharma Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 84. Bayer Non-ionic Iodine Contrast Media Product Portfolio Table 85. Bayer Recent Development Table 86. Sanochemia Company Information Table 87. Sanochemia Business Overview Table 88. Sanochemia Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 89. Sanochemia Non-ionic Iodine Contrast Media Product Portfolio Table 90. Sanochemia Recent Development Table 91. Imax Company Information Table 92. Imax Business Overview Table 93. Imax Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 94. Imax Non-ionic Iodine Contrast Media Product Portfolio Table 95. Imax Recent Development Table 96. Guerbet Group Company Information Table 97. Guerbet Group Business Overview Table 98. Guerbet Group Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 99. Guerbet Group Non-ionic Iodine Contrast Media Product Portfolio Table 100. Guerbet Group Recent Development Table 101. GE Healthcare Company Information Table 102. GE Healthcare Business Overview Table 103. GE Healthcare Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 104. GE Healthcare Non-ionic Iodine Contrast Media Product Portfolio Table 105. GE Healthcare Recent Development Table 106. Bracco Imaging Company Information Table 107. Bracco Imaging Business Overview Table 108. Bracco Imaging Non-ionic Iodine Contrast Media Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 109. Bracco Imaging Non-ionic Iodine Contrast Media Product Portfolio Table 110. Bracco Imaging Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Non-ionic Iodine Contrast Media Distributors List Table 114. Non-ionic Iodine Contrast Media Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Non-ionic Iodine Contrast Media Product Image Figure 2. Global Non-ionic Iodine Contrast Media Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-ionic Iodine Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-ionic Iodine Contrast Media Sales (2021-2032) & (K L) Figure 5. Global Non-ionic Iodine Contrast Media Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Non-ionic Iodine Contrast Media Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Iopamidol Image Figure 10. Iodixanol Image Figure 11. Iohexol Image Figure 12. Ioversol Image Figure 13. Others Image Figure 14. Global Non-ionic Iodine Contrast Media Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 15. Global Non-ionic Iodine Contrast Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Non-ionic Iodine Contrast Media Sales Volume Share by Type (2021-2032) Figure 17. Global Non-ionic Iodine Contrast Media Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Non-ionic Iodine Contrast Media Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Non-ionic Iodine Contrast Media Sales Value Share by Type (2021-2032) Figure 20. Hospitals Image Figure 21. Clinics Image Figure 22. Global Non-ionic Iodine Contrast Media Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 23. Global Non-ionic Iodine Contrast Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Non-ionic Iodine Contrast Media Sales Volume Share by Application (2021-2032) Figure 25. Global Non-ionic Iodine Contrast Media Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Non-ionic Iodine Contrast Media Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Non-ionic Iodine Contrast Media Sales Value Share by Application (2021-2032) Figure 28. Global Non-ionic Iodine Contrast Media Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 29. Global Non-ionic Iodine Contrast Media Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Non-ionic Iodine Contrast Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Non-ionic Iodine Contrast Media Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Non-ionic Iodine Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 33. North America Non-ionic Iodine Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Non-ionic Iodine Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Non-ionic Iodine Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Non-ionic Iodine Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Non-ionic Iodine Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Non-ionic Iodine Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 39. South America Non-ionic Iodine Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Non-ionic Iodine Contrast Media Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Non-ionic Iodine Contrast Media Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Non-ionic Iodine Contrast Media Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Non-ionic Iodine Contrast Media Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Iopamidol
  • Iodixanol
  • Iohexol
  • Ioversol
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • YRPG
  • Hengrui Medicine
  • BeiLu Pharma
  • Bayer
  • Sanochemia
  • Imax
  • Guerbet Group
  • GE Healthcare
  • Bracco Imaging

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-ionic Iodine Contrast Media Sales Value (2021-2032)
  4. 1.2.2 Global Non-ionic Iodine Contrast Media Sales Volume (2021-2032)
  5. 1.2.3 Global Non-ionic Iodine Contrast Media Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-ionic Iodine Contrast Media Market Dynamics
  1. 2.1 Non-ionic Iodine Contrast Media Industry Trends
  2. 2.2 Non-ionic Iodine Contrast Media Industry Drivers
  3. 2.3 Non-ionic Iodine Contrast Media Industry Opportunities and Challenges
  4. 2.4 Non-ionic Iodine Contrast Media Industry Restraints
3 Non-ionic Iodine Contrast Media Market by Company
  1. 3.1 Global Non-ionic Iodine Contrast Media Company Revenue Ranking in 2025
  2. 3.2 Global Non-ionic Iodine Contrast Media Revenue by Company (2021-2026)
  3. 3.3 Global Non-ionic Iodine Contrast Media Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-ionic Iodine Contrast Media Average Price by Company (2021-2026)
  5. 3.5 Global Non-ionic Iodine Contrast Media Company Ranking (2024-2026)
  6. 3.6 Global Non-ionic Iodine Contrast Media Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-ionic Iodine Contrast Media Company Product Type and Application
  8. 3.8 Global Non-ionic Iodine Contrast Media Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-ionic Iodine Contrast Media Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-ionic Iodine Contrast Media Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-ionic Iodine Contrast Media Market by Type
  1. 4.1 Non-ionic Iodine Contrast Media Type Introduction
  2. 4.1.1 Iopamidol
  3. 4.1.2 Iodixanol
  4. 4.1.3 Iohexol
  5. 4.1.4 Ioversol
  6. 4.1.5 Others
  7. 4.2 Global Non-ionic Iodine Contrast Media Sales Volume by Type
  8. 4.2.1 Global Non-ionic Iodine Contrast Media Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Non-ionic Iodine Contrast Media Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Non-ionic Iodine Contrast Media Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Non-ionic Iodine Contrast Media Sales Value by Type
  12. 4.3.1 Global Non-ionic Iodine Contrast Media Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Non-ionic Iodine Contrast Media Sales Value by Type (2021-2032)
  14. 4.3.3 Global Non-ionic Iodine Contrast Media Sales Value Share by Type (2021-2032)
5 Non-ionic Iodine Contrast Media Market by Application
  1. 5.1 Non-ionic Iodine Contrast Media Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Non-ionic Iodine Contrast Media Sales Volume by Application
  5. 5.2.1 Global Non-ionic Iodine Contrast Media Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-ionic Iodine Contrast Media Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Non-ionic Iodine Contrast Media Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Non-ionic Iodine Contrast Media Sales Value by Application
  9. 5.3.1 Global Non-ionic Iodine Contrast Media Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non-ionic Iodine Contrast Media Sales Value by Application (2021-2032)
  11. 5.3.3 Global Non-ionic Iodine Contrast Media Sales Value Share by Application (2021-2032)
6 Non-ionic Iodine Contrast Media Regional Sales and Value Analysis
  1. 6.1 Global Non-ionic Iodine Contrast Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-ionic Iodine Contrast Media Sales by Region (2021-2032)
  3. 6.2.1 Global Non-ionic Iodine Contrast Media Sales by Region: 2021-2026
  4. 6.2.2 Global Non-ionic Iodine Contrast Media Sales by Region (2027-2032)
  5. 6.3 Global Non-ionic Iodine Contrast Media Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-ionic Iodine Contrast Media Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-ionic Iodine Contrast Media Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-ionic Iodine Contrast Media Sales Value by Region (2027-2032)
  9. 6.5 Global Non-ionic Iodine Contrast Media Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-ionic Iodine Contrast Media Sales Value (2021-2032)
  12. 6.6.2 North America Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-ionic Iodine Contrast Media Sales Value (2021-2032)
  15. 6.7.2 Europe Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-ionic Iodine Contrast Media Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-ionic Iodine Contrast Media Sales Value (2021-2032)
  21. 6.9.2 South America Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-ionic Iodine Contrast Media Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-ionic Iodine Contrast Media Sales Value Share by Country, 2025 VS 2032
7 Non-ionic Iodine Contrast Media Country-level Sales and Value Analysis
  1. 7.1 Global Non-ionic Iodine Contrast Media Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-ionic Iodine Contrast Media Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-ionic Iodine Contrast Media Sales by Country (2021-2032)
  4. 7.3.1 Global Non-ionic Iodine Contrast Media Sales by Country (2021-2026)
  5. 7.3.2 Global Non-ionic Iodine Contrast Media Sales by Country (2027-2032)
  6. 7.4 Global Non-ionic Iodine Contrast Media Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-ionic Iodine Contrast Media Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-ionic Iodine Contrast Media Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-ionic Iodine Contrast Media Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-ionic Iodine Contrast Media Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-ionic Iodine Contrast Media Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 YRPG
  2. 8.1.1 YRPG Company Information
  3. 8.1.2 YRPG Business Overview
  4. 8.1.3 YRPG Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 YRPG Non-ionic Iodine Contrast Media Product Portfolio
  6. 8.1.5 YRPG Recent Developments
  7. 8.2 Hengrui Medicine
  8. 8.2.1 Hengrui Medicine Company Information
  9. 8.2.2 Hengrui Medicine Business Overview
  10. 8.2.3 Hengrui Medicine Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hengrui Medicine Non-ionic Iodine Contrast Media Product Portfolio
  12. 8.2.5 Hengrui Medicine Recent Developments
  13. 8.3 BeiLu Pharma
  14. 8.3.1 BeiLu Pharma Company Information
  15. 8.3.2 BeiLu Pharma Business Overview
  16. 8.3.3 BeiLu Pharma Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BeiLu Pharma Non-ionic Iodine Contrast Media Product Portfolio
  18. 8.3.5 BeiLu Pharma Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Non-ionic Iodine Contrast Media Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Sanochemia
  26. 8.5.1 Sanochemia Company Information
  27. 8.5.2 Sanochemia Business Overview
  28. 8.5.3 Sanochemia Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanochemia Non-ionic Iodine Contrast Media Product Portfolio
  30. 8.5.5 Sanochemia Recent Developments
  31. 8.6 Imax
  32. 8.6.1 Imax Company Information
  33. 8.6.2 Imax Business Overview
  34. 8.6.3 Imax Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Imax Non-ionic Iodine Contrast Media Product Portfolio
  36. 8.6.5 Imax Recent Developments
  37. 8.7 Guerbet Group
  38. 8.7.1 Guerbet Group Company Information
  39. 8.7.2 Guerbet Group Business Overview
  40. 8.7.3 Guerbet Group Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guerbet Group Non-ionic Iodine Contrast Media Product Portfolio
  42. 8.7.5 Guerbet Group Recent Developments
  43. 8.8 GE Healthcare
  44. 8.8.1 GE Healthcare Company Information
  45. 8.8.2 GE Healthcare Business Overview
  46. 8.8.3 GE Healthcare Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GE Healthcare Non-ionic Iodine Contrast Media Product Portfolio
  48. 8.8.5 GE Healthcare Recent Developments
  49. 8.9 Bracco Imaging
  50. 8.9.1 Bracco Imaging Company Information
  51. 8.9.2 Bracco Imaging Business Overview
  52. 8.9.3 Bracco Imaging Non-ionic Iodine Contrast Media Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bracco Imaging Non-ionic Iodine Contrast Media Product Portfolio
  54. 8.9.5 Bracco Imaging Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-ionic Iodine Contrast Media Value Chain Analysis
  2. 9.1.1 Non-ionic Iodine Contrast Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-ionic Iodine Contrast Media Sales Mode & Process
  6. 9.2 Non-ionic Iodine Contrast Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-ionic Iodine Contrast Media Distributors
  9. 9.2.3 Non-ionic Iodine Contrast Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research